Results 61 to 70 of about 3,747 (101)

老年男性2型糖尿病合并骨质疏松患者IGF-1及骨代谢指标的改变

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2008
【目的】 探讨老年男性2型糖尿病(T2DM)中合并骨质疏松患者的IGF-1及骨生化指标改变,为早期防治T2DM并发骨质疏松及其骨折提供防治理论依据?【方法】 根据双能X线骨密度仪对腰椎及左股骨颈骨密度的检测结果,并根据WHO推荐的骨质疏松诊断标准将89例老年男性2型糖尿病患者分为合并骨质疏松组(G1)和无骨质疏松组(G2),并分别测定这两组的血清胰岛素样生长因子-1(IGF-1)、骨钙素(BGP)、1型胶原异构C端肽(β-CTX)、降钙素(CT)、甲状旁腺素(PTH)、血钙(Ca)、磷(P ...
doaj  

[Liver-bone axis: novel mechanisms and strategies for MAFLD regulation]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Wang YW, Yan XZ, You H, Yang AT.
europepmc   +1 more source

[Diagnostic value of procalcitonin in neonatal early-onset sepsis]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi, 2020
Wang SY, Yu JL.
europepmc   +1 more source

[Curcumin improves osteoporosis in type 2 diabetic mice by inhibiting RANBP3L expression]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Zou X, Zhang X, Li P, Tian R, Lu X.
europepmc   +1 more source

脓毒症患者血浆可溶性尿激酶型纤溶酶原激活物受体与血清降钙素原水平变化的预后价值

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2014
摘 要: 【目的】 观察脓毒症患者血浆可溶性尿激酶型纤溶酶原激活物受体(suPAR)?血清降钙素原(PCT)水平的变化,探讨suPAR?PCT在脓毒症预后中的价值?【方法】 测定82例脓毒症患者?29例全身炎症反应综合征(SIRS)患者入组当天血浆suPAR?血清PCT水平,记录APACHEⅡ和SOFA评分?观察脓毒症存活组(n = 51)和死亡组(n = 31)入ICU第1?3?5?7天?出科或死亡当天血浆suPAR?血清PCT变化趋势,分析suPAR?PCT ...
doaj  

Home - About - Disclaimer - Privacy